- Everlife acquires Research Instruments Group and other laboratory suppliers to boost presence in strategic life sciences and clinical diagnostics segments in South East Asia
[Singapore, March 10, 2022]: Everlife Holdings Pte Ltd (“Everlife”), a leading market access and distribution company in India and South East […]
- Everlife expands life science and analytical presence in Malaysia and Singapore through investment in Analisa & Scientific Resources
[Singapore, January 2022]: Everlife Holdings Pte Ltd (“Everlife”), a leading market access and distribution company in India and South East […]
- Everlife’s Chemopharm invests in Malaysian medical equipment distributor Medigene Sdn. Bhd.
Kuala Lumpur, December 30, 2021 – Chemopharm Sdn. Bhd. (“Chemopharm”), an Everlife company and leading laboratory supplies and IVD distributor in […]
- Everlife and Boditech Med to collaborate to develop POCT market in select Asian countries
[Dusseldorf, November 15, 2021]: Everlife Holdings Pte. Ltd. (“Everlife”), a leading market access and medical device distributor in Asia, and Boditech Med Inc (“Boditech Med”), a leading manufacturer of […]
- Mr. Cleto Gerard S. Arnedo appointed as Chief Executive Officer of Lifeline Diagnostics Philippines
[Manila, November 8, 2021]: Lifeline Diagnostics Supplies, Inc. (“Lifeline”), the leading provider of In-Vitro Diagnostics (IVD) products and services in Philippines, […]
- Dr. Naveen Agnihotri joins Everlife Asia as Senior Advisor of Digital and Technology
[Singapore, August 19, 2021]: Everlife Holdings Pte. Ltd. (“Everlife”) has welcomed Dr. Naveen Agnihotri to the company as Senior Advisor […]
- Ramesh Subrahmanian joins Everlife Board
[Singapore, July 2, 2021]: Everlife Holdings Pte. Ltd. (“Everlife”), a leading manufacturer and distributor of medical devices and laboratory equipment and consumables in Asia, has appointed […]
- Dr. Pramod Kabra appointed as Chief Executive Officer of CPC Diagnostics, a subsidiary of Everlife Asia
[Chennai, May 10, 2021]: CPC Diagnostics Pvt. Ltd. (“CPC”), a leading provider of In-Vitro Diagnostics (IVD) products and services in […]
- Chemopharm Launches E-Commerce Store in Malaysia
Kuala Lumpur, May 2021 – Chemopharm Sdn Bhd, Everlife’s subsidiary in Malaysia, has launched its new E-Commerce Store (“eStore”) in […]
- Chemopharm Launches Revolutionary Novaerus Air Disinfection Devices in Malaysia
Kuala Lumpur, December, 2020 – Chemopharm Sdn Bhd, an Everlife company, has launched Novaerus air disinfection devices in Malaysia. Novaerus, […]
- Chemopharm wins 2020 ASEAN Business Award
Hanoi, November 13, 2020 – Chemopharm, an Everlife company, was awarded the ‘2020 ASEAN Business Award’ for their outstanding performance […]
- CPC Diagnostics launches first ICMR approved COVID-19 CLIA antibody test in India
Chennai, May 20, 2020 – CPC Diagnostics (‘CPC’), Chennai, a portfolio company of Everstone backed healthcare platform Everlife Holdings Pte. […]
- DV Medika marks launch of United Imaging in Indonesia with installation of uCT 760 at Stella Maris Hospital
October, 2019 – DV Medika, an Everlife investment and leading Indonesian distributor of medical devices, is proud to have installed […]
- Chemopharm appointed as Exclusive Channel Partner of PAC in Malaysia
October, 2019 – Chemopharm Sdn Bhd, an Everlife investment and leading laboratory and medical devices distributor headquartered in Malaysia, is […]
- Everstone-backed Everlife appoints Raman Gandotra as Chief Executive Officer
Singapore/Mumbai, September 9, 2019 – Everlife Holdings Pte. Ltd. (Everlife), a leading distributor and manufacturer of medical and laboratory equipment and […]
- Everlife joins the Asia Pacific Medical Technology Association (APACMed)!
Founded in 2014, the Asia Pacific Medical Technology Association (APACMed) represents manufacturers and suppliers of medical equipment, devices and in-vitro […]
- Chemopharm announces expanded distribution partnership with Mindray in Malaysia
April, 2019 – Chemopharm Sdn Bhd, an Everlife investment and leading laboratory and medical devices distributor headquartered in Malaysia, is […]
- CPC Diagnostics and YHLO jointly launch iFlash CLIA System in India
April 2019 – CPC Diagnostics, a leading IVD manufacturer and distributor in India, and YHLO, a leading company for immunoassays […]
- Everstone-backed Everlife invests in Chennai based CPC Diagnostics
Mumbai, March 13, 2019 – The Everstone Group via its healthcare platform Everlife has acquired a stake in Chennai based CPC […]
- Everstone invests in Chemopharm, a leading Southeast Asian distributor of medical products and solutions
Originally published on Everstone website here. Singapore, November 23, 2017 – The Everstone Group via its platform Everlife has acquired Malaysia-based […]
- Thought Leadership: The Evolution of COVID-19 Diagnostics
by Arjun Oberoi Since the first reported case of COVID-19 arose outside of China, it set the world on a […]
- Blog: All about Anti- Phospholipid Syndrome
By Dr.Sunitha Shaibu Group Product Manager (CPC Diagnostics) What is Anti-Phospholipid Syndrome (APS) ? Anti- Phospholipid syndrome is a rare […]
- Looking Forward: Building a Future-Ready Medical Device Distribution Platform
The global medical devices segment has undergone an exceptionally eventful year and is entering a dynamic new phase. In Vitro […]
- Thought Leadership: Laboratories and their services will be in the spotlight in a post-vaccine world
by Arjun Oberoi Recent weeks have been filled with positive news around promising vaccine candidates and the pace at which […]
- Case Study: Achieving success through active principal management
A successful distributor-principal relationship requires effort and time to build, and benefits both parties. We are fortunate that the principals […]
